512861278	512861278	CD	B-NP	O
|	|	NN	I-NP	O
NAFCH	NAFCH	NN	I-NP	O
|	|	NN	I-NP	O
85429130	85429130	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0620641	0620641	CD	B-NP	O
|	|	CC	I-NP	O
11/21/2006	11/21/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
chronic	chronic	JJ	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
LBBB	LBBB	NNP	B-NP	O
|	|	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/24/2006	6/24/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
9/22/2006	9/22/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	B-protein
SARP	SARP	NNP	B-NP	I-protein
,	,	,	O	O
TYRONE	TYRONE	NNP	B-NP	O
L	L	NNP	I-NP	O
230-12-53-3	230-12-53-3	CD	I-NP	O
Pla	Pla	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
9/24/06	9/24/06	CD	B-NP	O
AT	AT	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
Not	Not	NNP	I-NP	O
Applicable	Applicable	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
ESCOBEDO	ESCOBEDO	NNP	B-NP	O
,	,	,	O	O
FRANK	FRANK	NNP	B-NP	O
JULIUS	JULIUS	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Home	Home	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
LIPITOR	LIPITOR	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ATORVASTATIN	ATORVASTATIN	NN	I-NP	O
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/24/06	9/24/06	CD	B-NP	O
by	by	IN	B-PP	O
:	:	:	O	O
POTENTIALLY	POTENTIALLY	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
AZITHROMYCIN	AZITHROMYCIN	NNP	B-NP	O
&	&	CC	I-NP	O
ATORVASTATIN	ATORVASTATIN	NNP	I-NP	O
CALCIUM	CALCIUM	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
monitored	monitor	VBN	I-VP	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
AZITHROMYCIN	AZITHROMYCIN	NN	I-NP	I-protein
250	250	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	O
X	X	NNP	I-NP	O
3	3	CD	I-NP	O
doses	dose	NNS	I-NP	O
Starting	Start	VBG	B-VP	O
IN	IN	IN	B-PP	O
AM	AM	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
11/10	11/10	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
antacids	antacid	NNS	I-NP	O
Take	Take	VBP	B-VP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
Alert	Alert	NNP	I-NP	O
overridden	overridden	JJ	I-NP	O
:	:	:	O	O
Override	Override	NN	B-NP	O
added	add	VBN	B-VP	O
on	on	IN	B-PP	O
9/27/06	9/27/06	CD	B-NP	O
by	by	IN	B-PP	O
DZIUBAN	DZIUBAN	NNP	B-NP	O
,	,	,	O	O
GERMAN	GERMAN	NNP	B-NP	O
W.	W.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
SIMVASTATIN	SIMVASTATIN	NNP	B-NP	O
&	&	CC	I-NP	O
AZITHROMYCIN	AZITHROMYCIN	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
ECASA	ECASA	NNP	B-NP	B-protein
325	325	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
FLONASE	FLONASE	NNP	I-NP	I-protein
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FLUTICASONE	FLUTICASONE	NNP	I-NP	O
NASAL	NASAL	NNP	I-NP	O
SPRAY	SPRAY	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
SPRAY	SPRAY	NN	I-NP	O
NA	NA	NN	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
LANTUS	LANTUS	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
GLARGINE	GLARGINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
HUMALOG	HUMALOG	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
LISPRO	LISPRO	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
12	12	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
AC	AC	NNP	I-NP	O
COMBIVENT	COMBIVENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
IPRATROPIUM	IPRATROPIUM	NNP	I-NP	O
AND	AND	CC	O	O
ALBUTEROL	ALBUTEROL	NNP	B-NP	O
SULFATE	SULFATE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
2	2	CD	I-NP	O
PUFF	PUFF	NNP	I-NP	O
INH	INH	NNP	I-NP	O
QID	QID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/8	10/8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Wheezing	Wheezing	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
use	use	NN	B-NP	O
with	with	IN	B-PP	O
a	a	DT	B-NP	O
spacer	spacer	NN	I-NP	B-DNA
LORATADINE	LORATADINE	NN	I-NP	I-DNA
10	10	CD	I-NP	I-DNA
MG	MG	NNP	I-NP	I-DNA
PO	PO	NNP	I-NP	I-DNA
DAILY	DAILY	NNP	I-NP	I-DNA
Starting	Starting	NNP	I-NP	I-DNA
Today	Today	NNP	I-NP	I-DNA
-LRB-	-LRB-	NNP	I-NP	I-DNA
10/8	10/8	CD	I-NP	I-DNA
-RRB-	-RRB-	NNP	I-NP	I-DNA
Instructions	Instruction	NNPS	I-NP	I-DNA
:	:	:	O	O
you	you	PRP	B-NP	O
can	can	MD	B-VP	O
buy	buy	VB	I-VP	O
the	the	DT	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
counter	counter	NN	I-NP	O
version	version	NN	I-NP	O
of	of	IN	B-PP	O
this	this	DT	B-NP	O
medication	medication	NN	I-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Avoid	Avoid	JJ	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	B-DNA
instructs	instruct	NNS	I-NP	I-DNA
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

Give	Give	VB	B-VP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
METFORMIN	METFORMIN	NN	I-NP	O
1	1	CD	I-NP	O
,	,	,	I-NP	O
000	000	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
PRILOSEC	PRILOSEC	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OMEPRAZOLE	OMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/8	10/8	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Instructions	Instruction	NNPS	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
can	can	MD	B-VP	O
by	by	IN	B-PP	O
the	the	DT	B-NP	O
over	over	IN	B-PP	O
the	the	DT	B-NP	O
counter	counter	NN	I-NP	O
version	version	NN	I-NP	O
of	of	IN	B-PP	O
prilosec	prilosec	NN	B-NP	O
DIOVAN	DIOVAN	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
VALSARTAN	VALSARTAN	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
160	160	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
Override	Override	NNP	I-NP	O
Notice	Notice	NNP	I-NP	O
:	:	:	O	O
Override	Override	NNP	B-NP	O
added	add	VBD	B-VP	O
on	on	IN	B-PP	O
9/27/06	9/27/06	CD	B-NP	O
by	by	IN	B-PP	O
NAUMANN	NAUMANN	NNP	B-NP	O
,	,	,	O	O
CLAIR	CLAIR	NNP	B-NP	O
L.	L.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
on	on	IN	B-PP	O
order	order	NN	B-NP	O
for	for	IN	B-PP	O
POTASSIUM	POTASSIUM	NN	B-NP	O
CHLORIDE	CHLORIDE	NN	I-NP	O
IMMED	IMMED	NN	I-NP	O
.	.	.	O	O

REL	REL	NN	B-NP	B-protein
.	.	.	O	O

PO	PO	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
ref	ref	NN	I-NP	O
#	#	#	B-NP	O
138369983	138369983	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
POTENTIALLY	POTENTIALLY	NNP	I-NP	O
SERIOUS	SERIOUS	NNP	I-NP	O
INTERACTION	INTERACTION	NNP	I-NP	O
:	:	:	O	O
VALSARTAN	VALSARTAN	NNP	B-NP	O
&	&	CC	I-NP	O
POTASSIUM	POTASSIUM	NNP	I-NP	O
CHLORIDE	CHLORIDE	NNP	I-NP	O
Reason	Reason	NNP	I-NP	O
for	for	IN	B-PP	O
override	override	NN	B-NP	O
:	:	:	O	O
will	will	MD	B-VP	O
monitor	monitor	VB	I-VP	O
Number	Number	NNP	B-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
2100	2100	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
2	2	CD	B-NP	O
gram	gram	NN	I-NP	O
Sodium	Sodium	NN	I-NP	O
ACTIVITY	ACTIVITY	NN	I-NP	O
:	:	:	O	O
Resume	Resume	VB	B-VP	O
regular	regular	JJ	B-NP	O
exercise	exercise	NN	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Dr	Dr	NNP	B-NP	O
Teskey	Teskey	NNP	I-NP	O
745-074-1341	745-074-1341	CD	I-NP	O
call	call	NN	I-NP	O
to	to	TO	B-VP	O
make	make	VB	I-VP	O
appt	appt	NN	B-NP	O
at	at	IN	B-PP	O
your	your	PRP$	B-NP	O
convenience	convenience	NN	I-NP	O
1-2	1-2	NN	I-NP	O
weeks	week	NNS	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
NKA	NKA	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
chronic	chronic	JJ	B-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
atypical	atypical	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
PRINCIPAL	PRINCIPAL	JJ	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
chronic	chronic	JJ	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
LBBB	LBBB	NNP	B-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
htn	htn	NN	I-NP	O
iddm	iddm	NNP	I-NP	O
CRI	CRI	NNP	I-NP	O
Colon	Colon	NNP	I-NP	O
CA	CA	NNP	I-NP	O
Prostate	Prostate	NNP	I-NP	O
CA	CA	NNP	I-NP	O
hyperchol	hyperchol	NN	I-NP	O
otitis	otitis	NN	I-NP	O
externa	externa	NN	I-NP	O
bullous	bullous	JJ	I-NP	O
myringitis	myringitis	NN	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
upper	upper	JJ	B-NP	O
respiratory	respiratory	JJ	I-NP	O
sx	sx	NN	I-NP	O
**************************	**************************	SYM	B-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
63	63	CD	B-NP	O
yo	yo	NN	I-NP	O
M	M	NN	I-NP	O
w/hx	w/hx	NN	I-NP	O
of	of	IN	B-PP	O
IDDM	IDDM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
hyperchol	hyperchol	NN	B-NP	O
,	,	,	O	O
obesity	obesity	NN	B-NP	O
p/w	p/w	NN	I-NP	O
URI	URI	NN	I-NP	O
sx	sx	NN	I-NP	O
.	.	.	O	O

4	4	CD	B-NP	O
wks	wk	VBZ	B-VP	O
chronic	chronic	JJ	B-NP	O
productive	productive	JJ	I-NP	O
cough	cough	NN	I-NP	O
,	,	,	O	O
rhinorrhea	rhinorrhea	NN	B-NP	O
,	,	,	O	O
sensation	sensation	NN	B-NP	O
of	of	IN	B-PP	O
nasal	nasal	JJ	B-NP	O
discharge	discharge	NN	I-NP	O
down	down	RB	B-ADVP	O
back	back	RB	B-ADVP	O
of	of	IN	B-PP	O
throat	throat	NN	B-NP	O
.	.	.	O	O

Also	Also	RB	B-ADVP	O
w/assoc	w/assoc	NN	B-NP	O
episode	episode	NN	I-NP	O
of	of	IN	B-PP	O
mild	mild	JJ	B-NP	O
CP	CP	NN	I-NP	O
2	2	CD	B-NP	O
days	day	NNS	I-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
CP	CP	NN	B-NP	B-DNA
assoc	assoc	NN	I-NP	O
w/cough	w/cough	NN	I-NP	O
,	,	,	O	O
lasting	last	VBG	B-VP	O
min	min	NN	B-NP	O
,	,	,	O	O
did	do	VBD	B-VP	O
not	not	RB	I-VP	O
occur	occur	VB	I-VP	O
w/exertion	w/exertion	NN	B-NP	O
,	,	,	O	O
no	no	DT	B-NP	O
SOB	SOB	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
N/V/diaphoresis	N/V/diaphoresis	NN	I-NP	O
,	,	,	O	O
resolved	resolve	VBN	B-VP	O
spontaneously	spontaneously	RB	B-ADVP	O
.	.	.	O	O

Presented	Present	VBN	B-VP	O
to	to	TO	I-VP	O
ED	ED	VB	I-VP	O
2/2	2/2	CD	B-NP	O
cough	cough	NN	I-NP	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
keeping	keep	VBG	I-VP	O
him	him	PRP	B-NP	O
up	up	RP	B-PRT	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
F/C/SOB	F/C/SOB	NN	I-NP	B-protein
/	/	SYM	B-NP	O
DOE/PND/orthopnea	DOE/PND/orthopnea	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
LE	LE	NN	I-NP	O
edema	edema	NN	I-NP	O
.	.	.	O	O

Able	Able	NN	B-NP	O
to	to	TO	B-VP	O
walk	walk	VB	I-VP	O
3-4	3-4	CD	B-NP	O
miles	mile	NNS	I-NP	O
2-3	2-3	CD	B-NP	O
times	time	NNS	I-NP	O
per	per	IN	B-PP	O
wk	wk	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
exertional	exertional	JJ	I-NP	O
symptoms	symptom	NNS	I-NP	O
.	.	.	O	O

Noted	Note	VBN	B-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
LBBB	LBBB	NNP	B-NP	O
that	that	WDT	B-NP	O
was	be	VBD	B-VP	O
new	new	JJ	B-ADJP	O
from	from	IN	B-PP	O
last	last	JJ	B-NP	B-protein
ekg	ekg	NN	I-NP	I-protein
done	do	VBN	B-VP	I-protein
12	12	CD	B-NP	I-protein
yrs	yr	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	O
,	,	,	O	O
admitted	admit	VBN	B-VP	O
for	for	IN	B-PP	O
ROMI	ROMI	NN	B-NP	B-protein
.	.	.	O	O

***************************	***************************	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
as	as	IN	B-PP	O
above	above	IN	B-ADVP	O
,	,	,	O	O
colon	colon	NN	B-NP	O
CA	CA	NN	I-NP	O
s/p	s/p	NN	I-NP	O
partial	partial	JJ	I-NP	O
colectomy	colectomy	NN	I-NP	O
1992	1992	CD	I-NP	O
,	,	,	O	O
prostate	prostate	NN	B-NP	B-protein
CA	CA	NN	I-NP	I-protein
s/p	s/p	NN	I-NP	I-protein
XRT	XRT	NN	I-NP	I-protein
-LRB-	-LRB-	SYM	B-NP	I-protein
dx	dx	NN	I-NP	I-protein
6	6	CD	B-NP	I-protein
yrs	yr	NNS	I-NP	I-protein
ago	ago	IN	B-PP	O
-RRB-	-RRB-	NNP	B-NP	O
,	,	,	O	O
CRI	CRI	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
Cr	Cr	NNP	I-NP	O
1.0-1	1.0-1	CD	I-NP	O
.9	.9	CD	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
2/2	2/2	CD	I-NP	O
htn	htn	NN	I-NP	O
,	,	,	O	O
dm	dm	NN	B-NP	O
;	;	:	O	O
LBP	LBP	NN	B-NP	O
***************************	***************************	SYM	I-NP	O
MEDS	MEDS	NN	I-NP	O
:	:	:	O	O
diovan	diovan	NN	B-NP	O
,	,	,	O	O
asa	asa	NN	B-NP	O
,	,	,	O	O
lisinopril	lisinopril	NN	B-NP	O
,	,	,	O	O
lipitor	lipitor	NN	B-NP	O
,	,	,	O	O
metformin	metformin	NN	B-NP	O
,	,	,	O	O
lantus	lantus	NN	B-NP	O
,	,	,	O	O
humalog	humalog	NN	B-NP	O
***************************	***************************	SYM	I-NP	O
STUDIES	STUDIES	NN	I-NP	O
:	:	:	O	O
LABS	LABS	NN	B-NP	B-protein
:	:	:	O	O
nl	nl	NN	B-NP	B-protein
chem7	chem7	NN	I-NP	I-protein
,	,	,	O	O
nl	nl	NN	B-NP	B-protein
CBC	CBC	NNP	I-NP	O
,	,	,	O	O
neg	neg	NN	B-NP	O
cardiac	cardiac	JJ	I-NP	O
enzymes	enzyme	NNS	I-NP	O
x3	x3	CD	B-NP	O
CXR	CXR	NN	I-NP	B-protein
:	:	:	O	O
no	no	DT	B-NP	O
acute	acute	JJ	I-NP	O
process	process	NN	I-NP	O
****************************	****************************	SYM	B-NP	O
HOSPITAL	HOSPITAL	NN	I-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
63M	63M	NN	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
hx	hx	NN	I-NP	O
of	of	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
obesity	obesity	NN	B-NP	O
,	,	,	O	O
hyperlipidemia	hyperlipidemia	NN	B-NP	O
a/w	a/w	NN	I-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
2	2	CD	I-NP	O
d	d	NN	I-NP	O
ago	ago	RB	B-ADJP	O
atypical	atypical	JJ	I-ADJP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
etiology	etiology	NN	I-NP	O
with	with	IN	B-PP	O
LBBB	LBBB	NN	B-NP	B-protein
from	from	IN	B-PP	O
last	last	JJ	B-NP	O
ekg	ekg	NN	I-NP	O
in	in	IN	B-PP	O
1994	1994	CD	B-NP	O
C/V	C/V	NNP	I-NP	O
:	:	:	O	O
I	I	CD	B-NP	O
:	:	:	O	O
hx	hx	NN	B-NP	O
very	very	RB	B-ADJP	O
atypical	atypical	JJ	I-ADJP	O
of	of	IN	B-PP	O
cardiac	cardiac	JJ	B-NP	O
chest	chest	NN	I-NP	O
pain	pain	NN	I-NP	O
,	,	,	O	O
more	more	RBR	B-ADJP	O
likely	likely	JJ	I-ADJP	O
related	relate	VBN	B-VP	O
to	to	TO	B-PP	O
cough	cough	NN	B-NP	O
.	.	.	O	O

Given	Given	NNP	B-NP	O
LBBB	LBBB	NNP	I-NP	O
,	,	,	O	O
cardiac	cardiac	JJ	B-NP	B-protein
enzymes	enzyme	NNS	I-NP	I-protein
were	be	VBD	B-VP	O
checked	check	VBN	I-VP	O
and	and	CC	O	O
were	be	VBD	B-VP	O
negative	negative	JJ	B-ADJP	O
x	x	SYM	O	O
3	3	CD	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
would	would	MD	B-VP	O
have	have	VB	I-VP	O
expected	expect	VBN	I-VP	O
+	+	SYM	B-NP	O
enzymes	enzyme	NNS	I-NP	B-protein
on	on	IN	B-PP	O
initial	initial	JJ	B-NP	O
set	set	NN	I-NP	O
if	if	IN	B-SBAR	O
ischemia	ischemia	NN	B-NP	O
was	be	VBD	B-VP	O
present	present	JJ	B-NP	O
given	give	VBN	I-NP	O
pain	pain	NN	I-NP	O
was	be	VBD	B-VP	O
>	>	JJR	B-NP	O
24	24	CD	I-NP	O
hrs	hr	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
presentation	presentation	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Lipid	Lipid	NN	B-NP	O
panel	panel	NN	I-NP	O
shows	show	VBZ	B-VP	O
LDL	LDL	NN	B-NP	B-protein
at	at	IN	B-PP	O
goal	goal	NN	B-NP	O
for	for	IN	B-PP	O
diabetic	diabetic	JJ	B-NP	O
;	;	:	O	O
HDL	HDL	NN	B-NP	O
slightly	slightly	RB	B-ADJP	O
low	low	JJ	I-ADJP	O
but	but	CC	O	O
can	can	MD	B-VP	O
be	be	VB	I-VP	O
followed	follow	VBN	I-VP	O
up	up	RP	B-PRT	O
by	by	IN	B-PP	O
PCP	PCP	NN	B-NP	B-protein
.	.	.	O	O

Cont	Cont	NN	B-NP	O
ASA	ASA	NN	I-NP	O
and	and	CC	I-NP	O
statin	statin	NN	I-NP	O
.	.	.	O	O

Consider	Consider	VB	B-VP	O
outpt	outpt	JJ	B-NP	O
ETT-mibi	ETT-mibi	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LBBB	LBBB	NNP	I-NP	O
precludes	preclude	VBZ	B-VP	O
simple	simple	JJ	B-NP	O
ETT	ETT	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
but	but	CC	O	O
will	will	MD	B-VP	O
defer	defer	VB	I-VP	O
to	to	TO	B-PP	O
PCP	PCP	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
point	point	NN	I-NP	O
.	.	.	O	O

P	P	NN	B-NP	O
:	:	:	O	O
Cont	Cont	JJ	B-NP	O
home	home	NN	I-NP	O
anti-htnsive	anti-htnsive	JJ	I-NP	O
regimen	regimen	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
sx	sx	NN	I-NP	O
of	of	IN	B-PP	O
CHF	CHF	NN	B-NP	B-protein
to	to	TO	B-VP	O
warrant	warrant	VB	I-VP	O
echo	echo	NN	B-NP	O
at	at	IN	B-PP	O
this	this	DT	B-NP	O
time	time	NN	I-NP	O
.	.	.	O	O

R	R	NN	B-NP	O
:	:	:	O	O
new	new	JJ	B-NP	O
LBBB	LBBB	NN	I-NP	B-protein
since	since	IN	B-PP	O
last	last	JJ	B-NP	B-protein
ekg	ekg	NN	I-NP	I-protein
12	12	CD	B-NP	I-protein
yrs	yr	NNS	I-NP	I-protein
ago	ago	RB	B-ADVP	O
,	,	,	O	O
no	no	DT	B-NP	O
events	event	NNS	I-NP	O
on	on	IN	B-PP	O
tele	tele	NN	B-NP	O
Pulm/Chronic	Pulm/Chronic	NNP	I-NP	O
Cough	Cough	NNP	I-NP	O
:	:	:	O	O
Most	Most	JJS	B-NP	O
likely	likely	JJ	I-NP	O
gerd	gerd	NN	I-NP	O
v	v	NN	I-NP	O
PND	PND	NN	I-NP	O
v	v	NN	I-NP	O
bronchitis	bronchitis	NN	I-NP	O
.	.	.	O	O

Given	Give	VBN	B-NP	O
sx	sx	NN	I-NP	O
worse	worse	JJR	B-ADJP	O
at	at	IN	B-PP	O
night	night	NN	B-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
have	have	VB	I-VP	O
GERD	GERD	NNP	B-NP	O
component	component	JJ	I-NP	O
given	give	VBN	I-NP	O
body	body	NN	I-NP	O
habitus	habitus	NN	I-NP	O
-	-	HYPH	O	O
trial	trial	NN	B-NP	O
of	of	IN	B-PP	O
PPI	PPI	NN	B-NP	B-protein
.	.	.	O	O

Given	Give	VBN	B-NP	O
sx	sx	NN	I-NP	O
for	for	IN	B-PP	O
1	1	CD	B-NP	O
mo	mo	NN	I-NP	O
,	,	,	O	O
started	start	VBN	B-VP	O
on	on	IN	B-PP	O
z-pak	z-pak	NN	B-NP	B-DNA
.	.	.	O	O

Added	Add	VBN	B-NP	O
flonase	flonase	NN	I-NP	O
and	and	CC	I-NP	O
loratidine	loratidine	NN	I-NP	O
for	for	IN	B-PP	O
PND	PND	NN	B-NP	O
.	.	.	O	O

Inhalers	Inhaler	NNS	B-NP	O
for	for	IN	B-PP	O
wheezing	wheeze	VBG	B-VP	O
prn	prn	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
improved	improve	VBD	B-VP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
d/c	d/c	NN	B-NP	B-protein
-RRB-	-RRB-	NN	I-NP	I-protein
.	.	.	O	O

ENDO	ENDO	NN	B-NP	B-protein
:	:	:	O	O
cont	cont	VB	B-VP	O
home	home	NN	B-NP	O
regimen	regimen	NN	I-NP	O
ONC	ONC	NN	I-NP	O
:	:	:	O	O
no	no	DT	B-NP	O
active	active	JJ	I-NP	O
inpatient	inpatient	NN	I-NP	O
issues	issue	NNS	I-NP	O
RENAL	RENAL	NN	I-NP	O
:	:	:	O	O
at	at	IN	B-PP	O
baseline	baseline	NN	B-NP	O
creatinine	creatinine	NN	I-NP	O
FEN	FEN	NN	I-NP	O
:	:	:	O	O
cardiac	cardiac	JJ	B-NP	O
,	,	,	I-NP	O
diabetic	diabetic	JJ	I-NP	O
,	,	,	I-NP	O
diet	diet	NN	I-NP	O
PROPHY	PROPHY	NN	I-NP	O
:	:	:	O	O
lovenox	lovenox	NN	B-NP	O
,	,	,	O	O
nexium	nexium	NN	B-NP	O
CODE	CODE	NN	I-NP	O
:	:	:	O	O
full	full	JJ	B-NP	O
DISPO	DISPO	NN	I-NP	O
:	:	:	O	O
f/u	f/u	SYM	B-NP	O
w	w	NN	I-NP	O
/	/	SYM	B-NP	O
PCP	PCP	NN	I-NP	O
for	for	IN	B-PP	O
poss	poss	JJ	B-NP	O
outpt	outpt	JJ	I-NP	O
stress	stress	NN	I-NP	O
imaging	imaging	NN	I-NP	O
ADDITIONAL	ADDITIONAL	NN	I-NP	O
COMMENTS	COMMENTS	NNS	I-NP	O
:	:	:	O	O
DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
1	1	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Follow	Follow	NNP	I-NP	O
up	up	RP	B-PRT	O
with	with	IN	B-PP	O
Dr	Dr	NNP	B-NP	O
Kreager	Kreager	NNP	I-NP	O
he	he	PRP	B-NP	O
can	can	MD	B-VP	O
decide	decide	VB	I-VP	O
to	to	TO	I-VP	O
have	have	VB	I-VP	O
you	you	PRP	B-NP	O
undergo	undergo	VBP	B-VP	O
a	a	DT	B-NP	O
stress	stress	NN	I-NP	O
test	test	NN	I-NP	O
as	as	IN	B-PP	O
an	an	DT	B-NP	O
outpatient	outpatient	NN	I-NP	B-protein
2	2	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Take	Take	VB	B-VP	O
your	your	PRP$	B-NP	O
medications	medication	NNS	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
PIH	PIH	NN	B-NP	O
,	,	,	O	O
DEANDRE	DEANDRE	NNP	B-NP	O
B.	B.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
LE67	LE67	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
9/24/06	9/24/06	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

